1. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation.
- Author
-
Sun, Q., Matta, H., Lu, G., and Chaudhary, P. M.
- Subjects
- *
HERPESVIRUSES , *PROTEINS , *INTERLEUKIN-8 , *HOMOLOGY (Biology) , *APOPTOSIS , *BINDING sites - Abstract
Human herpesvirus 8 (HHV-8) encodes a viral FLICE inhibitory protein (vFLIP), called K13, with homology to the prodomain of caspase 8. K13 has been postulated to protect virally infected cells against death receptor-induced apoptosis. We report that K13 leads to constitutive upregulation of IL-8 secretion by transcriptional upregulation of its promoter. K13-induced IL-8 promoter activation is dependent on an intact NF-κB-binding site and is associated with increased binding of classical NF-κB pathway subunits p65, c-Rel and p50, respectively. IL-8 production is defective in K13 mutants defective in classical NF-κB activation and is blocked by genetic and pharmacological inhibitors of this pathway. In contrast, K13 failed to activate the JNK/AP-1 pathway and deletion of AP-1-binding site in the IL-8 promoter or use of a specific JNK inhibitor had only a partial effect on K13-induced IL-8 promoter activation. Collectively, above results demonstrate that K13 is a major mediator of IL-8 production and therapeutic agents targeting K13-induced NF-κB pathway may have a role in the treatment of conditions in which HHV-8-induced IL-8 production plays a pathogenic role.Oncogene (2006) 25, 2717–2726. doi:10.1038/sj.onc.1209298; published online 16 January 2006 [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF